Form 4 for GOSS Gossamer Bio, Inc.
Accepted 2023-07-26 00:00:00 ET · period of report 2023-07-24 · accession 0001728117-23-000099 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-07-26 | 2023-07-24 | GOSS | Hasnain Faheem | Pres, CEO, Dir | A - Grant | $1.82 | +540.2K | 5.04M | +12% | +$983.1K |
| DI | 2023-07-26 | 2023-07-24 | GOSS | Hasnain Faheem | Pres, CEO, Dir | A - Grant | $0.13 | +135.0K | 135.0K | New | +$17.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-24 | A | A | 540,176 | $1.82 | 5,036,073 | I By family trust | — | — | |
| 2 | Derivative | Common Stock Purchase Warrants | 2023-07-24 | A | A | 135,044 | $0.13 | 135,044 | I By family trust | $2.04 · 2023-07-24 to 2028-07-24 | 135,044 Common Stock |